Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: pixantrone dimaleate
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)